BAC
Bank of America Corporation
BAC's fundamentals are strong: its operating margin rose 5 points to 35% and revenue grew 15%. At 12x earnings, it's trading in line with its usual 13x. Analysts expect earnings growth.
UBS
UBS Group AG
There isn't enough reported data to score UBS yet.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
UBS Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Strong | |
| N/A | |
| N/A |
UBS's profitability is currently strong. There isn't enough data to rate its revenue. Free cash flow and net leverage aren't meaningful measures for financial services companies like UBS.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | — |
| Current | 12x | $50.51 | — |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC has the edge over UBS in the historical PE scenario, which offers more potential upside but is not a forecast.
UBS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 7.4x | $17.70 | -63% |
| Fair | 9.8x | $23.26 | -52% |
| Forward | 11x | $48.44 | — |
| Current | 20x | $48.44 | — |
| Expensive | 21x | $49.06 | +1.3% |
Historical ranges are pointers, not guarantees.
UBS's PE is 20x, but its earnings don't support one, so it isn't a reliable read right now.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for BAC, with profitability improving.
UBS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for UBS, with profitability improving.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
BAC's earnings per share have climbed steadily: $4.19 over the past year, up 14% from the year before, and higher year over year for eight quarters in a row.
UBS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.32 | +82% |
| Q4 2025 | $2.38 | +57% |
| Q2 2025 | $1.91 | +19000% |
| Q1 2025 | $1.53 | -81% |
| Q4 2024 | $1.52 | -81% |
| Q2 2024 | $0.01 | -100% |
| Q1 2024 | $8.18 | +317% |
| Q4 2023 | $7.98 | +255% |
| Q2 2023 | $9.86 | +340% |
UBS has the edge over BAC in the latest year-over-year earnings comparison.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
BAC's revenue has grown year over year for 10 quarters in a row: $30B last quarter, up 6.7% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC's operating margin was 30% last quarter, down 3.7 points from the same quarter a year ago.
UBS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q4 2025 | $24.9B | +3.9% |
| Q2 2025 | $18.3B | -0.2% |
| Q1 2025 | $18.9B | -3.4% |
| Q4 2024 | $24B | +6.3% |
| Q2 2024 | $18.3B | +33% |
| Q1 2024 | $19.6B | +71% |
| Q4 2023 | $22.6B | +39% |
| Q2 2023 | $13.8B | +58% |
UBS has the edge over BAC in the latest year-over-year revenue comparison.
| Quarter | Margin | YoY |
|---|---|---|
| Q4 2025 | 18% | +11 points |
| Q2 2025 | 12% | +1 points |
| Q1 2025 | 11% | +20 points |
| Q4 2024 | 12% | -168 points |
| Q2 2024 | 7.2% | -4.7 points |
| Q1 2024 | 11% | -15 points |
| Q4 2023 | -8.8% | -38 points |
| Q2 2023 | 180% | +153 points |
UBS's operating margin was 18% last quarter, up 11 points from the same quarter a year ago.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
BAC's free cash flow was $41.4B over the past year, down 33% from the year before. Free cash flow isn't a meaningful measure for financial services companies like BAC.
UBS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2025 | $5B | +$5.1B |
| Q1 2025 | $14.8B | +33% |
| Q2 2024 | -$186M | -100% |
| Q1 2024 | $11.1B | +$36.6B |
| Q2 2023 | $42.3B | +$51.8B |
| Q1 2023 | -$25.5B | -195% |
| Q2 2022 | -$9.5B | -$6.5B |
| Q1 2022 | $26.9B | +$26.9B |
UBS's free cash flow was $30.7B over the past year, down 10% from the year before. Free cash flow isn't a meaningful measure for financial services companies like UBS.
BAC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -72M shares |
| 1 year | -5.3% | -405M shares |
| 3 years | -11% | -854M shares |
| 5 years | -15% | -1.3B shares |
| Available history | -24% | -2.2B shares |
BAC has the edge over UBS on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6B |
| Q2 2026 | $6B |
| Q1 2026 | $7.2B |
| Q4 2025 | $6.3B |
| Q3 2025 | $5.3B |
| Q2 2025 | $5.3B |
| Q1 2025 | $4.5B |
| Q4 2024 | $3.5B |
BAC spent $25.6B buying back its own shares over the past year, up 37% from the year before.
UBS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.5% | -16.3M shares |
| 1 year | -2.1% | -69M shares |
| 3 years | -9.3% | -337M shares |
| 5 years | -15% | -563M shares |
UBS has 3.3B diluted shares, down 2.1% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2025 | $619.1M |
| Q1 2025 | $1.3B |
| Q2 2024 | $813M |
| Q1 2024 | $969.1M |
| Q2 2023 | $78.1M |
| Q1 2023 | $2.2B |
| Q2 2022 | $1.6B |
| Q1 2022 | $1.9B |
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC's net debt is about 6.4 years of its operating earnings (EBITDA), down from 8.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BAC.
UBS Net Leverage
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
UBS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 48.9 | Neutral |
| Stochastic | 20.3 | Neutral |
UBS's weekly RSI is 49 (neutral) and its Stochastic is 20 (neutral).
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC has the edge over UBS on valuation relative to its sector.
UBS PE vs Financial Services Sector
| Metric | UBS | Sector median | Relative |
|---|---|---|---|
| PE | 20x | 13x | 56% above |
| PE % | 83 | 63 | 20 pts above |
UBS is trading at 20x earnings, a 56% premium to the Financial Services sector's median of 13x, though its earnings don't support one.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
BAC has fallen below most of its moving averages, though it's still 19% above its 200-week average.
UBS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $47.9 | 1.1% above |
| 20 week MA | $51.0 | 5% below |
| 50 week MA | $46.9 | 3.4% above |
| 100 week MA | $40.9 | 18% above |
| 200 week MA | $33.8 | 43% above |
UBS has the edge over BAC on trend strength, trading above more of its moving averages.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has finished higher in four of the last six years. It's down 10% so far in 2026.
UBS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $12.5 | $14.1 | +13% |
| 2021 | $14.1 | $17.8 | +27% |
| 2022 | $17.8 | $18.6 | +4.5% |
| 2023 | $18.6 | $30.9 | +66% |
| 2024 | $30.9 | $30.7 | -0.7% |
| 2025 | $30.7 | $47.3 | +54% |
| 2026 YTD | $47.3 | $48.4 | +2.5% |
UBS has the edge over BAC on returns for 2026, with the stronger performance.